Meet our
leadership team
Get to know our Board of Directors, Executive Leadership Team and ownership structure.
Our Board of Directors and Executive Leadership Team have broad and global management experience, comprehensive biotech expertise and in-depth knowledge of our business.
Board of Directors
Executive Leadership Team
Our ownership structure
Novonesis has approximately 100.000 shareholders. Through Novo Holdings, the Novo Nordisk Foundation is the controlling shareholder in Novonesis. Novo Holdings holds 25.50% of the shares and controls 63.35% of the votes.
Novonesis’ stock consists of two types: A and B shares. Both shares have a nominal value of DKK 2 per share, but an A share carries 10 times as many votes as a B share. Novo holdings controls all the A shares.